Graziano S - Search Results

1

PD-L1 protein expression assessed by immunohistochemistry is neither prognostic nor predictive of benefit from adjuvant chemotherapy in resected non-small cell lung cancer.

Tsao MS, Le Teuff G, Shepherd FA, Landais C, Hainaut P, Filipits M, Pirker R, Le Chevalier T, Graziano S, Kratze R, Soria JC, Pignon JP, Seymour L, Brambilla E. Tsao MS, et al. Among authors: graziano s. Ann Oncol. 2017 Apr 1;28(4):882-889. doi: 10.1093/annonc/mdx003. Ann Oncol. 2017. PMID: 28137741 Free PMC article.

2

Phase II trial of etoposide and cisplatin for refractory small cell lung cancer: a Cancer and Leukemia Group B Study.

Graziano SL, Lee K, Propert KJ, Tinsley R, Hayes DM, Green M, Comis RL. Graziano SL, et al. Med Pediatr Oncol. 1990;18(1):22-6. doi: 10.1002/mpo.2950180105. Med Pediatr Oncol. 1990. PMID: 2152956 Review.

3

The use of neuroendocrine immunoperoxidase markers to predict chemotherapy response in patients with non-small-cell lung cancer.

Graziano SL, Mazid R, Newman N, Tatum A, Oler A, Mortimer JA, Gullo JJ, DiFino SM, Scalzo AJ. Graziano SL, et al. J Clin Oncol. 1989 Oct;7(10):1398-406. doi: 10.1200/JCO.1989.7.10.1398. J Clin Oncol. 1989. PMID: 2550590

4

Preoperative evaluation of stage I and stage II non-small cell lung cancer.

Hatter J, Kohman LJ, Mosca RS, Graziano SL, Veit LJ, Coleman M. Hatter J, et al. Among authors: graziano sl. Ann Thorac Surg. 1994 Dec;58(6):1738-41. doi: 10.1016/0003-4975(94)91673-x. Ann Thorac Surg. 1994. PMID: 7979746

5

Nonoperative management of non-small cell lung cancer: the current cancer and leukemia group B experience.

Green MR, Kosty MP, Muscato JJ, Graziano S, Dillman RO, Clamon GH, Herndon J 2nd. Green MR, et al. Among authors: graziano s. Semin Oncol. 1994 Jun;21(3 Suppl 6):60-5. Semin Oncol. 1994. PMID: 8052875 Review.

6

The prognostic significance of neuroendocrine markers and carcinoembryonic antigen in patients with resected stage I and II non-small cell lung cancer.

Graziano SL, Tatum AH, Newman NB, Oler A, Kohman LJ, Veit LJ, Gamble GP, Coleman MJ, Barmada S, O'Lear S. Graziano SL, et al. Cancer Res. 1994 Jun 1;54(11):2908-13. Cancer Res. 1994. PMID: 8187076

7

A randomized phase II study of ifosfamide/mesna/cisplatin plus G-CSF or etoposide/cisplatin plus G-CSF in advanced non-small cell lung cancer: a Cancer and Leukemia Group B study.

Graziano SL, Valone FH, Herndon JE 2nd, Crawford J, Richards F 2nd, Rege VB, Clamon G, Green MR. Graziano SL, et al. Lung Cancer. 1996 Jun;14(2-3):315-29. doi: 10.1016/0169-5002(96)00556-9. Lung Cancer. 1996. PMID: 8794413 Clinical Trial.

8

Pretreatment minimal staging and prognostic factors for non-small cell lung cancer.

Feld R, Abratt R, Graziano S, Jassem J, Lacquet L, Ninane V, Paesmans M, Rocmans P, Schiepers C, Stahel R, Stephens R. Feld R, et al. Among authors: graziano s. Lung Cancer. 1997 Jun;17 Suppl 1:S3-10. doi: 10.1016/s0169-5002(97)00637-5. Lung Cancer. 1997. PMID: 9213295 Review. No abstract available.

9

Prognostic significance of Ki-67 immunostaining and symptoms in resected stage I and II non-small cell lung cancer.

Mehdi SA, Etzell JE, Newman NB, Weidner N, Kohman LJ, Graziano SL. Mehdi SA, et al. Among authors: graziano sl. Lung Cancer. 1998 May;20(2):99-108. doi: 10.1016/s0169-5002(98)00027-0. Lung Cancer. 1998. PMID: 9711528

10

A study of filgrastim (rG-CSF) priming of etoposide/cisplatin in advanced non-small cell lung cancer.

Mehdi SA, Perry MC, Herndon JE 2nd, Crawford J, Young R, Graziano SL. Mehdi SA, et al. Among authors: graziano sl. J Interferon Cytokine Res. 1998 Aug;18(8):623-7. doi: 10.1089/jir.1998.18.623. J Interferon Cytokine Res. 1998. PMID: 9726444 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

294 results

Search Page

Filters